NWBO
Northwest Biotherapeutics Inc

13,433
Mkt Cap
$362.88M
Volume
2.07M
52W High
$0.4788
52W Low
$0.1684
PE Ratio
-3.87
NWBO Fundamentals
Price
$0.2439
Prev Close
$0.2364
Open
$0.241
50D MA
$0.2466
Beta
0.03
Avg. Volume
3.69M
EPS (Annual)
-$0.0686
P/B
-3.55
Rev/Employee
$55,280.00
Loading...
Loading...
Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
25

Frequently Asked Questions

What is Market Cap of Northwest Biotherapeutics Inc?
What is the 52-week high for Northwest Biotherapeutics Inc?
What is the 52-week low for Northwest Biotherapeutics Inc?
What is Northwest Biotherapeutics Inc stock price today?
What was Northwest Biotherapeutics Inc stock price yesterday?
What is the PE ratio of Northwest Biotherapeutics Inc?
What is the Price-to-Book ratio of Northwest Biotherapeutics Inc?
What is the 50-day moving average of Northwest Biotherapeutics Inc?
How many employess does Northwest Biotherapeutics Inc has?

Latest NWBO News

View
No NWBO news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.